Defiance Nasdaq 100 Income Target ETF (QQQT)

coco clear bevs available... 

This is just a scam and the worst thing is that it's very hard to sell it to write it off.

almost 500k trading today. Are we getting closer to an update??

At least boards not dead 

$BCTX BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
https://www.globenewswire.com/news-release/2026/07/07/3323056/0/en/briacell-engages-consulting-and-branding-firms-to-support-commercial-and-market-access-evaluation-of-bria-imt

BCDS is correcting within a longer-term bullish

trend. Although its MACD is presently below the signal line, shares remain 226.9% above an upwards sloping 200-day moving average. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.

Ask down to .44

Seems you were right, GRLF could really fly on strong volume

Good morning beautiful people, #People make triple your money 💰 today maybe more, - short squeezeheadedhere $TOP - with this stock TOP - TOP FINANCIAL GROUP https://toppriceprediction.com/

Dr. Dukes is a venture partner with OrbiMed, which is huge! DWTX LONG💰

https://www.orbimed.com/leadership/

https://investorshub.advfn.com/uimage/uploads/2026/7/7/kytibIMG_5620.jpeg

Another post-ReverseSplit stock turns into a turd...is there really a product? No REVENUES to be found...only DEEP LOSSES.

Oil and Hydrogen Fuel stocks are breaking out from dip, Iran and US are still in a war.

If you're new here, take 10 minutes to read Q7's very informative post about GNIS. Well worth the time.

Oil and Hydrogen Fuel stocks are breaking out from dip, Iran and US are still in a war.

AI Overview Analysts predict a 12-month average target price of $6.00 for Circle8 Group Inc (NASDAQ: $CIRC). Trading near $0.83, this target represents a potential upside of more than 600%. However, the stock carries high risk due to recent operating losses and ongoing market volatil

Nice post on X Right on point
DG
@Courage_wins
$ONDS

The market is simply not buying what Ondas is building.

But what we need to see more of is not another acquisition announcement or another slide deck explaining the vision.

We ne

Unfortunately, I am in a couple very illiquid and dead stocks for the time being... until they are not. So, right now I sit as I started buying up the shares back at .0003 into .0005. Definitely not much to move this but people could help by sharing the potential of $FITY in rooms and groups, anyone

Agree. As long as there is usage of AI inference, there will be a a huge need to move data to prevent bottlenecks. No hyperscaler will want their GPU’s sitting idle for any amount of time, waiting to receive or send data.

Dr. Lain Dukes has a very impressive resume folks! DWTX💰

Dr. Dukes is a Venture Partner at OrbiMed Advisors LLC. He previously served as Senior Vice President and Head of Business Development and Licensing for Merck Research Laboratories. Prior to joining Merck, Dr. Dukes was

Can't hold a bid on the otcid(pinksheets) but headed back to the NYSE? Ummmm nah... In order to get back to the NYSE, FOXO will have to cross many hurdles in which they are no where able to do so at this point in time...Nearly impossible any time soon....Like Satter said, just a bunch of bs to strin

down $1.40 ...someone is making money

PCGC - Or it's signaling fraud. How is it one company can have 31.26% profit margins when everyone else is at 2-6%? Makes no sense. But when mgt is not being paid, and you have a Nigerian auditor, and a dilution scheme designed to explode, almost any profit margin is possible!

https:/

Yves said "as we are engaging more and more Foundries, and more and more Customers" listen in the Q&A starting at 35 minutes for 2 minutes

https://youtu.be/W0ajt4XECrM

So, how many Foundries has LWLG "ported" it's PDK into at this point, my guess is at least the followi

U.S.-Iran Updates: Tankers hit in Strait of Hormuz as Tehran threatens to ditch talks over Trump's threats

Oil and Hydrogen Fuels on watch prices are going up (AGAIN) $DIA

Veteran Biopharma Executive and Venture Investor to Lead Newly Formed Dogwood Advisory Board in advance of Halneuron® Phase 2b Data Which is Projected for Fall of 2026

ALPHARETTA, Ga., June 30, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Compa